guest ::
Intensified cytarabine dose during consolidation in adult AML patients under 65 years is not associated with survival benefit: real-world data from the German SAL-AML registry
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
In
Journal of Cancer Research and Clinical Oncology 149(8), Seiten/Artikel-Nr.:4611-4621
2022
Published: 28 September 2022
Online
DOI: 10.18154/RWTH-CONV-249800
DOI: 10.1007/s00432-022-04356-9
URL: https://publications.rwth-aachen.de/record/860863/files/860863.pdf
Einrichtungen
OpenAccess: 
PDF
Dokumenttyp
Journal Article
Format
online, print
Sprache
English
Anmerkung
Peer reviewed article
Externe Identnummern
SCOPUS: SCOPUS:2-s2.0-85139055903
WOS Core Collection: WOS:000860391100001
PubMed: pmid:36167894
Interne Identnummern
RWTH-CONV-249800
Datensatz-ID: 860863
Beteiligte Länder
Germany
; 
; 
; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Life Sciences ; DEAL Springer ; Ebsco Academic Search ; Essential Science Indicators ; IF < 5 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
|
The record appears in these collections: |
PDF